Overview
Shares of Align Technology (NASDAQ:ALGN) fell 2% on Tuesday after the European Commission said it has opened an antitrust investigation into the company. The inquiry will examine whether Align engaged in tying - specifically, whether customers who buy the company's iTero intra-oral scanners in the European Economic Area were required or pressured to use Invisalign clear aligners.
What the investigation covers
The European Commission's probe is focused on potential breaches of EU competition rules related to tying practices. According to the announcement, the investigation was launched following a complaint from a competitor. The Commission will evaluate the company's commercial practices around sales of iTero scanners and any conditions attached to those sales that could limit customer choice in orthodontic treatment products.
Company products at the center
Align, a United States-based manufacturer, produces both the iTero intra-oral scanners used by dental and orthodontic practitioners to capture digital impressions of patients' teeth, and Invisalign clear aligners used in orthodontic care. The probe will specifically look at whether Align required or effectively tied scanner purchasers to using its Invisalign aligners.
Market reaction
Stocks moved lower on the news, with Align shares slipping 2% on Tuesday. The price reaction reflects investor sensitivity to regulatory risks that can affect commercial arrangements and competitive dynamics in markets for clinical equipment and treatment products.
Context and limits
The European Commission's announcement notes the investigation was prompted by a competitor complaint. Beyond that procedural information, the Commission will carry out its assessment under relevant EU competition rules. The statement does not provide additional facts about specific contracts, customers, or alleged commercial terms. The scope of the probe is confined to the European Economic Area and to the question of tying in relation to iTero scanners and Invisalign aligners.
Implications to watch
At this stage, the inquiry is investigatory. It will determine whether there is evidence of tying that would constitute a breach of competition law in the EEA. Any further developments, findings, or formal charges would be announced by the European Commission as the process advances.
Summary of facts
- European Commission opened an antitrust investigation into Align Technology over suspected tying of iTero scanners to Invisalign aligners in the EEA.
- The probe was triggered by a competitor's complaint.
- Align is a U.S.-based maker of both iTero scanners and Invisalign clear aligners.
- Align shares fell 2% on Tuesday following the announcement.